Jihye Ahn

Jihye Ahn

Auto-generated profile, based on publicly available information

Jihye Ahn

Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JSJiyoon Shin
Jiyoon Shin
SKSujin Kim
Sujin Kim
JLJooyoung Lee
Jooyoung Lee
HGHyerin Gu
Hyerin Gu
JAJihye Ahn
Jihye Ahn
YLYu Jin Lee
Yu Jin Lee
Background: Cognitive behavioral therapy for insomnia (CBTi) is the first-line therapy for chronic insomnia. Mobile app–based CBTi (MCBTi) can enhance the accessibility of CBTi treatment; however, few studies have evaluated the effectiveness of MCBTi using a multicenter, randomized controlled trial design. Objective: We aimed to assess the efficacy of Somzz, an MCBTi that provides real-time and tailored feedback to users, through comparison with an active comparator app. Methods: In our multicenter, single-blind randomized controlled trial study, participants were recruited from 3 university hospitals and randomized into a Somzz group and a sleep hygiene education (SHE) group at a 1:1 ratio. The intervention included 6 sessions for 6 weeks, with follow-up visits over a 4-month period. The Somzz group received audiovisual sleep education, guidance on relaxation therapy, and real-time feedback on sleep behavior. The primary outcome was the Insomnia Severity Index score, and secondary outcomes included sleep diary measures and mental health self-reports. We analyzed the outcomes based on the intention-to-treat principle. Results: A total of 98 participants were randomized into the Somzz (n=49, 50%) and SHE (n=49, 50%) groups. Insomnia Severity Index scores for the Somzz group were significantly lower at the postintervention time point (9.0 vs 12.8; t95=3.85; F2,95=22.76; ηp2=0.13; P<.001) and at the 3-month follow-up visit (11.3 vs 14.7; t68=2.61; F2,68=5.85; ηp2=0.03; P=.01) compared to those of the SHE group. The Somzz group maintained their treatment effect at the postintervention time point and follow-ups, with a moderate to large effect size (Cohen d=–0.62 to –1.35; P<.01 in all cases). Furthermore, the Somzz group showed better sleep efficiency (t95=–3.32; F2,91=69.87; ηp2=0.41; P=.001), wake after sleep onset (t95=2.55; F2,91=51.81; ηp2=0.36; P=.01), satisfaction (t95=–2.05; F2,91=26.63; ηp2=0.20; P=.04) related to sleep, and mental health outcomes, including depression (t95=2.11; F2,94=29.64; ηp2=0.21; P=.04) and quality of life (t95=–3.13; F2,94=54.20; ηp2=0.33; P=.002), compared to the SHE group after the intervention. The attrition rate in the Somzz group was 12% (6/49). Conclusions: Somzz outperformed SHE in improving insomnia, mental health, and quality of life. The MCBTi can be a highly accessible, time-efficient, and effective treatment option for chronic insomnia, with high compliance. Trial Registration: Clinical Research Information Service (CRiS) KCT0007292; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22214&search_page=L

31 March 2021 in Chronobiology in Medicine
Verified
Journal Article
Open access
PDF file
JAJihye Ahn
Jihye Ahn
JLJooyoung Lee
Jooyoung Lee
SKSeog Ju Kim
Seog Ju Kim

6 July 2023 in JMIR Preprints
Verified
Preprint
Open access
JSJiyoon Shin
Jiyoon Shin
SKSujin Kim
Sujin Kim
JLJooyoung Lee
Jooyoung Lee
HGHyerin Gu
Hyerin Gu
JAJihye Ahn
Jihye Ahn
YLYu Jin Lee
Yu Jin Lee
BACKGROUND Cognitive behavioral therapy for insomnia (CBTi) is the first-line therapy for chronic insomnia. Mobile app–based CBTi (MCBTi) can enhance the accessibility of CBTi treatment; however, few studies have evaluated the effectiveness of MCBTi using a multicenter, randomized controlled trial design. OBJECTIVE We aimed to assess the efficacy of Somzz, an MCBTi that provides real-time and tailored feedback to users, through comparison with an active comparator app. METHODS In our multicenter, single-blind randomized controlled trial study, participants were recruited from 3 university hospitals and randomized into a Somzz group and a sleep hygiene education (SHE) group at a 1:1 ratio. The intervention included 6 sessions for 6 weeks, with follow-up visits over a 4-month period. The Somzz group received audiovisual sleep education, guidance on relaxation therapy, and real-time feedback on sleep behavior. The primary outcome was the Insomnia Severity Index score, and secondary outcomes included sleep diary measures and mental health self-reports. We analyzed the outcomes based on the intention-to-treat principle. RESULTS A total of 98 participants were randomized into the Somzz (n=49, 50%) and SHE (n=49, 50%) groups. Insomnia Severity Index scores for the Somzz group were significantly lower at the postintervention time point (9.0 vs 12.8; t95=3.85; F2,95=22.76; ηp2=0.13; P<.001) and at the 3-month follow-up visit (11.3 vs 14.7; t68=2.61; F2,68=5.85; ηp2=0.03; P=.01) compared to those of the SHE group. The Somzz group maintained their treatment effect at the postintervention time point and follow-ups, with a moderate to large effect size (Cohen d=–0.62 to –1.35; P<.01 in all cases). Furthermore, the Somzz group showed better sleep efficiency (t95=–3.32; F2,91=69.87; ηp2=0.41; P=.001), wake after sleep onset (t95=2.55; F2,91=51.81; ηp2=0.36; P=.01), satisfaction (t95=–2.05; F2,91=26.63; ηp2=0.20; P=.04) related to sleep, and mental health outcomes, including depression (t95=2.11; F2,94=29.64; ηp2=0.21; P=.04) and quality of life (t95=–3.13; F2,94=54.20; ηp2=0.33; P=.002), compared to the SHE group after the intervention. The attrition rate in the Somzz group was 12% (6/49). CONCLUSIONS Somzz outperformed SHE in improving insomnia, mental health, and quality of life. The MCBTi can be a highly accessible, time-efficient, and effective treatment option for chronic insomnia, with high compliance. CLINICALTRIAL Clinical Research Information Service (CRiS) KCT0007292; https://cris.nih.go.kr/cris/search/detailSearch.do?seq=22214&search_page=L

31 March 2026 in Chronobiology in Medicine
Verified
Journal Article
Open access
PDF file
NLNarae Lee
Narae Lee
JAJihye Ahn
Jihye Ahn
HKHaein Kim
Haein Kim
SKSeog Ju Kim
Seog Ju Kim
Objective: This study investigated the association between chronotype and dysfunctional sleep-related beliefs in psychiatric outpatients presenting with sleep disturbance. Methods: This study analyzed medical records of 117 psychiatric outpatients with sleep disturbance (mean age 54.24±15.02 years; 65.8% female). Chronotype was assessed using the reduced Morningness-Eveningness Questionnaire (rMEQ). Sleep-related beliefs were evaluated using the Dysfunctional Beliefs and Attitudes about Sleep scale (DBAS-16). The relationship between chronotype and sleep-related beliefs and the interaction effect of age on their relationship were examined. Results: There was a significant negative association between rMEQ and DBAS-16 (r=-0.267, p<0.01, n=117), indicating that a stronger evening preference was associated with more pronounced dysfunctional sleep beliefs. This association remained significant after adjusting for age and sex (β=-0.299, p<0.01) or after controlling for depression, anxiety, insomnia, daytime sleepiness, and sleep quality (β=-0.277, p<0.01). The rMEQ score was independently associated with DBAS-16, accounting for 7% of the total variance. This negative relationship remained robust even after adjusting for all potential covariates including clinical and demographic factors (β=-0.277, p=0.003). There was a significant interaction of age group on the association between rMEQ and DBAS-16 (F(4, 108)=3.211, p=0.016). The effect of chronotype on dysfunctional beliefs was more evident among middle-aged and older patients. Conclusion: Chronotype is independently associated with dysfunctional beliefs about sleep in psychiatric outpatients with sleep disturbance.